HBP/O-GlcNAcylation Metabolic Axis Regulates Bone Resorption Outcome

Area of Science:

• * Cellular and Molecular Biology
• * Bone Biology and Metabolism
• * Metabolic Regulation of Cell Function

Background:

• * Osteoclasts are critical for bone mass regulation, exhibiting high metabolic activity.
• * Metabolic pathways significantly influence cellular differentiation and function.
• * The hexosamine biosynthetic pathway (HBP) is a key metabolic route impacting cellular processes.

Purpose of the Study:

• * To investigate the role of the HBP and O-GlcNAcylation in osteoclast differentiation and bone resorption.
• * To determine how O-GlcNAcylation influences the mode of bone resorption.
• * To evaluate the therapeutic potential of targeting OGT in bone loss models.

Main Methods:

• * Pharmacological inhibition of O-GlcNAc transferase (OGT) using OSMI-1.
• * Genetic deletion of OGT in osteoclasts.
• * In vitro osteoclast differentiation and resorption assays with exogenous N-acetylglucosamine (GlcNAc).
• * Time-lapse microscopy to observe osteoclast behavior.
• * In vivo studies using osteoclast-specific OGT-deficient mice in an apical periodontitis model.

Main Results:

• * OGT inhibition and genetic deletion reduced osteoclast differentiation and key marker expression (NFATc1, cathepsin K).
• * Exogenous GlcNAc enhanced osteoclast formation, demineralization, and promoted trench resorption mode.
• * Osteoclast-specific OGT deficiency increased bone density and reduced bone loss in an apical periodontitis model.
• * OGT deletion decreased inflammatory bone loss and the number of osteoclasts in vivo.

Conclusions:

• * The HBP/O-GlcNAcylation axis is a novel regulator of osteoclast differentiation and bone resorption mode.
• * Targeting OGT presents a potential therapeutic strategy for bone diseases characterized by excessive bone resorption.
• * O-GlcNAcylation specifically promotes an aggressive trench resorption phenotype in human osteoclasts.